K-ras status in squamous cell anal carcinoma (SCC): It's time for target-oriented treatment?

Cancer Chemotherapy and Pharmacology

Volumn 65, Issue 1, 2009, Pages 197-199

  Zampino, Maria Giulia ^a   Magni, Elena ^a   Sonzogni, Angelica ^a   Renne, Giuseppe ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Chemotherapy; EGFR; K ras status; Squamous cell anal cancer

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; FLUOROPYRIMIDINE; PLATINUM COMPLEX;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; ONCOGENE K RAS; PELVIS; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RETROSPECTIVE STUDIES;

EID: 70349626262     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00280-009-1117-3     Document Type: Article

References (10)

1. JR Daling MM Madeleine LG Johnsson, et al. 2004 Human papillomavirus, smoking, and sexual practices in the aetiology of anal cancer Cancer 101 270 280 15241823 10.1002/cncr.20365 (Pubitemid 38890829)
2. PR Fuchschuber M Rodriguez-Bigas T Weber, et al. 1997 Anal canal and perianal epidermoid cancers J Am Coll Surg 185 5 494 505
3. RLM Ruíz-Godoy CM Garcia-Cuellar NE Herrera González, et al. 2006 Mutational analysis of K-ras and Ras protein expression in larynx squamous cell carcinoma J Exp Clin Cancer Res 25 1 73 78
4. C Bokemeyer I Bondarenko A Makhson, et al. 2009 Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer J Clin Oncol 27 5 663 671 19114683 10.1200/JCO.2008.20.8397 1:CAS:528:DC%2BD1MXjsVCjsrk%3D
5. G Alvarez A Perry BR Tan, et al. 2006 Expression of epidermal growth factor receptor in squamous cell carcinoma of anal canal is independent of gene amplification Modern Pathol 19 942 949 10.1038/modpathol.3800608 1:CAS:528:DC%2BD28Xls1KitLw%3D (Pubitemid 43910473)
6. LH Le R Chetty MJ Moore 2005 Epidermal growth receptor expression in anal canal carcinoma Am J Clin Pathol 124 20 23 15923158 10.1309/X4UADHVN317V2XMW 1:CAS:528:DC%2BD2MXmvVGnsbY%3D
7. Ajani J, Wang X, Izzo J et al (2009) Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation. Dig Dis Sci 28 Apr (Epub ahead of print)
8. D Atkins KA Reiffen CL Tegtmeier, et al. 2004 Immunohistochemical detection of EGFR in paraffin-embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections J Histochem Cytochem 52 7 893 901 15208356 10.1369/jhc.3A6195.2004 1:CAS:528:DC%2BD2cXls1alurk%3D (Pubitemid 38857154)
9. LR Hiorn HJ Scholefield JG Palmer, et al. 1990 Ki-ras oncogene mutations in non-HPV-associated anal carcinoma J Pathol 161 99 103 10.1002/path.1711610203 (Pubitemid 20195785)
10. LK Phan PM Hoff 2007 Evidence of clinical activity for cetuximab combined with irinotecan in a patient with refractory anal canal squamous-cell carcinoma. Report of a case Dis Colon Rectum 50 3 395 398 17252287 10.1007/s10350-006-0786-9 (Pubitemid 46393970)